Hector Asia Holdings II Pte. Ltd., promoter of healthcare global enterprises , released a non-disposal undertaking on 7,16,77,991 equity shares on September 17, 2025. The release removes the encumbrance created through a facility agreement dated February 23, 2025, with Hongkong and Shanghai Banking Corporation Limited. The undertaking was previously intimated to the stock exchanges on June 10, 2025.

The disclosure was submitted under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Hector Asia Holdings II Pte. Ltd. confirmed that, along with persons acting in concert, specifically KIA EBT II Scheme 1, no new encumbrances have been created on the company's equity shares during the financial year ended March 31, 2026, beyond those already disclosed.

Key Details of the Transaction

The filing confirms that the promoter group remains compliant with disclosure requirements regarding substantial acquisition of shares and takeovers. The release of the encumbrance provides clarity on the status of the promoter's shareholding.

HealthCare Global Enterprises Limited has initiated a postal ballot process to seek shareholder approval for five special resolutions, including the adoption of a new employee stock option scheme and the reappointment of an independent director. The resolutions, which also cover the revision of remuneration for the Executive Director and Chief Executive Officer, require shareholder consent through remote e-voting. The record date for determining eligibility is June 05, 2026.

The company has proposed the HCG Employee Stock Option Scheme – 2026 (HCG ESOS 2026), which seeks approval to grant a maximum of 74,21,455 stock options. These options, representing 4.97% of the total share capital, are exercisable into equity shares of face value INR 10 each. The scheme aims to incentivize employees, including those of subsidiary and associate companies, by aligning their interests with the company's growth.

Key Resolutions

The postal ballot notice outlines the following special business items:

Executive Compensation and Appointments

The resolutions include specific provisions for key personnel. Dr. Manish Mattoo, Executive Director and CEO, is eligible to receive up to 18,55,364 options under the ESOP scheme, representing 1.24% of the diluted equity share capital. Additionally, the company seeks approval to revise his remuneration structure, effective April 1, 2026, to a base pay of INR 2,75,00,000 per annum and a variable pay of INR 1,25,00,000 per annum.

Mr. Rajiv Maliwal has been recommended for reappointment as an Independent Director for a term of five years effective from May 25, 2026. The Board has proposed a remuneration of INR 35,00,000 per annum for his second term, payable quarterly. This remuneration is consistent with that paid to other Independent Directors on the Board.

Voting Timeline and Process

The remote e-voting facility, managed by KFin Technologies Limited, is available to shareholders whose names appear on the register of members as on June 05, 2026. The voting period commenced at 9:00 a.m. on June 09, 2026, and will conclude at 5:00 p.m. on July 08, 2026. Shareholders must cast their votes electronically during this window, as no physical postal ballot forms will be issued.

The results of the postal ballot, along with the Scrutinizer’s Report, are scheduled to be declared on or before July 10, 2026. The company has engaged Mr. V. Sreedharan and Mr. Pradeep B. Kulkarni of M/s V. Sreedharan & Associates as Scrutinizers to oversee the voting process.